These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31082767)

  • 1. Synthesis and preclinical evaluation of the CRTH2 antagonist [
    Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR
    Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
    Gervais FG; Sawyer N; Stocco R; Hamel M; Krawczyk C; Sillaots S; Denis D; Wong E; Wang Z; Gallant M; Abraham WM; Slipetz D; Crackower MA; O'Neill GP
    Mol Pharmacol; 2011 Jan; 79(1):69-76. PubMed ID: 20943773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.
    Gallant M; Beaulieu C; Berthelette C; Colucci J; Crackower MA; Dalton C; Denis D; Ducharme Y; Friesen RW; Guay D; Gervais FG; Hamel M; Houle R; Krawczyk CM; Kosjek B; Lau S; Leblanc Y; Lee EE; Levesque JF; Mellon C; Molinaro C; Mullet W; O'Neill GP; O'Shea P; Sawyer N; Sillaots S; Simard D; Slipetz D; Stocco R; Sørensen D; Truong VL; Wong E; Wu J; Zaghdane H; Wang Z
    Bioorg Med Chem Lett; 2011 Jan; 21(1):288-93. PubMed ID: 21106375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Cheung P; Amin MA; Zhang B; Lechi F; Korsgren O; Eriksson J; Odell LR; Eriksson O
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramatroban-Based Analogues Containing Fluorine Group as Potential
    Huang LA; Huang KX; Tu J; Kandeel F; Li J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Visualization of β-Cells by Targeting of GPR44.
    Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O
    Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRTH2 antagonist MK-7246: a synthetic evolution from discovery through development.
    Molinaro C; Bulger PG; Lee EE; Kosjek B; Lau S; Gauvreau D; Howard ME; Wallace DJ; O'Shea PD
    J Org Chem; 2012 Mar; 77(5):2299-309. PubMed ID: 22335767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of [¹¹C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver.
    Jahan M; Johnström P; Nag S; Takano A; Korsgren O; Johansson L; Halldin C; Eriksson O
    Nucl Med Biol; 2015 Apr; 42(4):387-94. PubMed ID: 25633247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of [
    Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
    Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azaindoles as potent CRTH2 receptor antagonists.
    Simard D; Leblanc Y; Berthelette C; Zaghdane MH; Molinaro C; Wang Z; Gallant M; Lau S; Thao T; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Houle R; Lévesque JF
    Bioorg Med Chem Lett; 2011 Jan; 21(2):841-5. PubMed ID: 21185722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases.
    Sandham DA; Arnold N; Aschauer H; Bala K; Barker L; Brown L; Brown Z; Budd D; Cox B; Docx C; Dubois G; Duggan N; England K; Everatt B; Furegati M; Hall E; Kalthoff F; King A; Leblanc CJ; Manini J; Meingassner J; Profit R; Schmidt A; Simmons J; Sohal B; Stringer R; Thomas M; Turner KL; Walker C; Watson SJ; Westwick J; Willis J; Williams G; Wilson C
    Bioorg Med Chem; 2013 Nov; 21(21):6582-91. PubMed ID: 24021582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas.
    Di Gialleonardo V; Signore A; Scheerstra EA; Visser AK; van Waarde A; Dierckx RA; de Vries EF
    J Nucl Med; 2012 Nov; 53(11):1755-63. PubMed ID: 23000748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).
    Tasaki M; Kobayashi M; Tenda Y; Tsujimoto S; Nakazato S; Numazaki M; Hirano Y; Matsuda H; Terasaka T; Miyao Y; Shimizu Y; Hirayama Y
    Eur J Pharm Sci; 2013 Jun; 49(3):434-40. PubMed ID: 23624353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy.
    Calbet M; Andrés M; Armengol C; Bravo M; Eichhorn P; López R; García-González V; Roberts R; Miralpeix M
    Pharmacol Res; 2016 Sep; 111():208-216. PubMed ID: 27317944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging of GPR44 by Antagonist [
    Cheung P; Zhang B; Puuvuori E; Estrada S; Amin MA; Ye S; Korsgren O; Odell LR; Eriksson J; Eriksson O
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33923731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin D2 signaling mediated by the CRTH2 receptor is involved in MK-801-induced cognitive dysfunction.
    Onaka Y; Shintani N; Nakazawa T; Kanoh T; Ago Y; Matsuda T; Hashimoto R; Ohi K; Hirai H; Nagata KY; Nakamura M; Kasai A; Hayata-Takano A; Nagayasu K; Takuma K; Ogawa A; Baba A; Hashimoto H
    Behav Brain Res; 2016 Nov; 314():77-86. PubMed ID: 27481693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
    Skrtic S; Tyrberg B; Broberg M; Ericsson H; Schnecke V; Kjaer M; Hompesch M; Andersson EM; Ryberg E; Aivazidis A; Wennberg Huldt C; Löfgren L; Morrow L; Parkinson J; Rydén-Bergsten T; Watkins E; Sörhede Winzell M
    PLoS One; 2018; 13(12):e0208998. PubMed ID: 30557325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass.
    Eriksson O
    Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Vidal B; Karpenko IA; Liger F; Fieux S; Bouillot C; Billard T; Hibert M; Zimmer L
    Nucl Med Biol; 2017 Dec; 55():1-6. PubMed ID: 28917111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.